Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc.
Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc.
Opinion
NOTE: This order is nonprecedential United States Court of Appeals for the Federal Circuit SANOFI-AVENTIS DEUTSCHLAND GMBH, Plaintiff-Appellee, v. GENENTECH, INC., Defendant-Appellant, AND BIOGEN IDEC INC., Defendant.
2012-1454 Appeal from the United States District Court for the Northern District of California in consolidated case nos. 08-CV-4909 and 09-CV-4919, Judge Susan Illston.
ON MOTION ORDER Genentech, Inc. moves for the court to schedule oral argument in the case in September. Sanofi-Aventis Deutschland GmbH opposes.
SANOFI-AVENTIS DEUTSCHLAND V. GENENTECH, INC. 2 By the time the motion was received by the court, the September calendar had been schedu1ed. The court previously denied a motion to expedite oral argument Upon consideration thereof, IT Is ORDERED THAT: The motion is denied. Oral argument will be sched- uled in the usual course.
FoR THE CoURT 1 /s/ J an Horbaly Date J an Horbaly Clerk cc: William E. Solander, Esq.
Charles K. Verhoeven, Esq. F|\_Eg APPEA|.SFOH u's.T?l%li=§-ESFSAL C\RCU\T SEP 1 1 ZUTL JANHURBA[Y CLE¥K
Case-law data current through December 31, 2025. Source: CourtListener bulk data.